Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
72
datasets available to search
ShareScore release 0.9.0
Dataset results
72 results for “primary myelofibrosis”
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT03165734. IPD Sharing: NO. Countries: 24. Publications: 1.
HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/E
ClinicalTrials.gov study NCT01668173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
ClinicalTrials.gov study NCT02087059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential
ClinicalTrials.gov study NCT02124746. IPD Sharing: NO. Countries: 5. Publications: 0.
JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT02251821. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
ClinicalTrials.gov study NCT01558739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
ClinicalTrials.gov study NCT03427866. IPD Sharing: NO. Countries: 1. Publications: 0.
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
ClinicalTrials.gov study NCT01758588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis
ClinicalTrials.gov study NCT01149681. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
ClinicalTrials.gov study NCT02421354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT01369498. IPD Sharing: NO. Countries: 1. Publications: 0.
Integrative Analysis of Gene and miRNA expression profiles in Primary Myelofibrosis CD34+ cells
GEO Series GSE53482. Homo sapiens; synthetic construct. 146 samples. Type: Expression profiling by array; Non-coding RNA profiling by array.
Comparison of gene expression in megakaryocytes derived from primary myelofibrosis or healthy individuals
GEO Series GSE84638. Homo sapiens. 24 samples. Type: Expression profiling by array.
Therapeutic activity of GARP:TGF-b1 blockade in murine primary myelofibrosis
GEO Series GSE216221. Mus musculus. 28 samples. Type: Expression profiling by high throughput sequencing.
Single cell transcriptomc analysis of CD34+ cells from primary myelofibrosis patient
GEO Series GSE153319. Homo sapiens. 3 samples. Type: Expression profiling by high throughput sequencing.
DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies II
GEO Series GSE277866. Homo sapiens. 12 samples. Type: Methylation profiling by genome tiling array.
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT06397313. IPD Sharing: NO. Countries: 2. Publications: 0.
PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
ClinicalTrials.gov study NCT04054245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
ClinicalTrials.gov study NCT06327100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT01730248. IPD Sharing: NO. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.